Global ETD Search

1	Epidemiology of chronic non-specific lung disease (chronic Bronchitis) A critical analysis of three field surveys of CNSLD carried out in the Netherlands. Lende, R. van der. January 1969 (has links) Thesis--University Hospital at Groningen. / At head of title: University of Groningen. The Organization for Health Research T.N.O. Bibliography: v. 1, p. 147-159. Bronchitis Bronchitis. Medical geography
2	Epidemiology of chronic non-specific lung disease (chronic Bronchitis) A critical analysis of three field surveys of CNSLD carried out in the Netherlands. Lende, R. van der. January 1969 (has links) Thesis--University Hospital at Groningen. / At head of title: University of Groningen. The Organization for Health Research T.N.O. Bibliography: v. 1, p. 147-159. Bronchitis. Medical geography Bronchitis
3	Environment and bronchitis in the federal territory, Kuala Lumpur, Malaysia Ahmad, Shaharuddin January 1988 (has links) No description available. 610 Bronchitis in Kuala Lumpur
4	Globule leucocytes and respiratory diseases in cattle Akpavie, Stephen Owarioro January 1985 (has links) No description available. 636.089 Bovine parasitic bronchitis
5	Aspects of the immumobiology of Dictyocaulus viviparus infection McKeand, Jacqueline B. January 1992 (has links) No description available. 636.089 Bovine parasitic bronchitis
6	Pathogenesis of Haemophilus influenzae respiratory infection in COPD patients effects of neutrophil defensins on the interaction of Haemophilus influenzae with airway epithelial cells / Leeuwen-Gorter, Annelies Danielle van, January 2002 (has links) Proefschrift Universiteit van Amsterdam. / Rugtitel: Pathogenesis of Haemophilus influenzae infection in COPD patients. Met lit. opg. - Met samenvatting in het Nederlands. Haemophilus influenzae. Bronchitis
7	Characterization of infectious bronchitis virus isolates discovered during the 2004 avian influenza outbreak of the Delmarva Peninsula Foltz, Jeffrey Andrew. January 2008 (has links) Thesis (M.S.)--University of Delaware, 2008. / Principal faculty advisor: Jack Gelb, Dept. of Animal & Food Sciences. Includes bibliographical references. Birds Avian influenza Bronchitis.
8	Häufigkeit und Ătiologie der chronischen Bronchitis und des Lungenemphysems Kistner, Manfred, January 1900 (has links) Inaug.-Diss.--Erlangen-Nürnberg. / Vita. Includes bibliographical references. Bronchitis. Emphysema, Pulmonary.
9	Changes in maximal expiratory flows after postural drainage with and without aerosol therapy in subjects with chronic bronchitis Leonard, Mary Ann January 1978 (has links) No description available. Bronchitis. Aerosol therapy. Patients -- Positioning.
10	Desenvolvimento e avaliação da eficácia de uma vacina inativada do vírus da bronquite infecciosa aviária encapsulado em nanopartículas de quitosana / Lopes, Priscila Diniz. January 2017 (has links) Orientador: Hélio José Montassier / Coorientador: Renata Fonseca Vianna Lopez / Banca: Cintia Hiromi Okino / Banca:Rafael Antonio Casarin Penha Filho / Banca: Edison Luiz Durigon / Banca: Rosangela Zacarias Machado / Resumo: Vacinação é a forma mais eficiente para prevenir e controlar a infecção pelo vírus da bronquite infecciosa (VBI). Vacinas formuladas com nanopartículas de quitosana têm sido utilizadas como sistema de entrega de antígenos pela via mucosa e imunopotenciador. O objetivo do presente estudo foi desenvolver e avaliar a eficácia de uma vacina inativada formulada com o genótipo BR-I do VBI encapsulado em nanopartículas de quitosana (VBI-CS) administrada por via mucosa em aves. Além disso, objetivou-se comparar a eficácia da vacina desenvolvida com a de uma vacina inativada convencional do mesmo vírus incorporada a um adjuvante oleoso (Montanide ISA 71) (VBI-O), administrada por via intramuscular. Foram avaliadas as respostas imunes humoral e celular (RIC) nos compartimentos de mucosa e sistêmico induzidas pelas vacinas VBI-CS e VBI-O quando associadas ou não a uma vacina viva atenuada da estirpe H120 do VBI. A proteção induzida pelos diferentes protocolos vacinais foi avaliada após o desafio com a estirpe homóloga virulenta do genótipo BR-I. A vacina VBI-CS usada sozinha induziu altos níveis de anticorpos IgA anti-VBI na mucosa e também a expressão dos genes de RIC (CD8β, Granzima A e IFNγ) na traqueia, enquanto que associada a uma vacina viva atenuada heteróloga, induziu maiores níveis de anticorpos IgG anti-VBI (mucosa e sistêmico) e RIC caracterizada pelo aumento da expressão dos genes CD8β, Granzima A e IFNγ, principalmente na traqueia. Além disso, foi observado que os protocolo... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Vaccination is the most efficient way to prevent and control infection caused by the infectious bronchitis virus (IBV). Vaccines formulated with chitosan nanoparticles have been used as an antigen delivery system in mucosal and immunopotentiator. The aim of this study was to develop and evaluate the efficacy of an inactivated vaccine formulated with IBV BR-I genotype encapsulated in chitosan nanoparticles (IBV-CS) administered by the mucosal route in chickens. In addition, this study aimed to compare the efficacy of the developed vaccine with a conventional inactivated vaccine of the same virus incorporated into oily adjuvant (Montanide ISA 71) (IBV-O) administered intramuscularly. The humoral and cellular (CMI) mediated immune responses in the mucosal and systemic compartments induced by IBV-CS and IBV-O vaccines were evaluated, when these vaccines were associated or not with a live attenuated H120 serotype vaccine. The protection induced by the different vaccine protocols was evaluated after the challenge with the virulent homologous strain of BR-I genotype. The IBV-CS vaccine used alone induced high levels of IgA anti-IBV antibodies in mucosal and also the expression of CMI genes (CD8β, Granzyme A and IFNγ genes) in the trachea, while associated with a live attenuated vaccine, it induced higher levels of IgG anti-IBV antibodies (mucosal and systemic compartments) and the expression of CMI genes, mainly in trachea. In addition, the vaccine protocols using the IBV-CS vaccine... (Complete abstract click electronic access below) / Doutor Resposta imune. Bronquite. Galinhas. Nanopartículas. Quitosana. Bronchitis.

Search results